Daiichi Sankyo webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference

Company invites individual and institutional investors, as well as advisors, to log-on to view the presentation

TOKYO, June 13, 2016 /CNW/ -- Daiichi Sankyo Co., Ltd (JP: 4568.T, OTC Pink: DSNKY)  based in Tokyo, and focused on pharmaceutical manufacturing, today announced that their June 9 presentation from Senior Director, IR group, Mr. Junichi Onuma is now available for on-demand viewing in the dbVIC Deutsche Bank American Depositary Receipt (ADR) Virtual Investor Conference.

LINK:    www.adr.db.com/dbvic

Daiichi Sankyo's presentation will be available 24/7 for 90 days. Investors may download shareholder materials from the virtual trade booth in the Exhibits section of the event.

About Daiichi Sankyo

Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in both mature and emerging markets. With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to its strong portfolio of medicines for hypertension, dyslipidemia, bacterial infections, and thrombotic disorders, the Group's research and development is focused on bringing forth novel therapies in cardiovascular-metabolic diseases, pain management, and oncology, including biologics. For more information, please visit: www.daiichisankyo.com.

SOURCE Daiichi Sankyo Co., Ltd.

DAIICHI SANKYO CO., LTD., William R. Henning, Manager, Media Relations Team, Public Relations Group , [email protected], [phone]